Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
Background: The prognostic value of Immunoscore was evaluated in Stage II/III colon cancer (CC) patients, but it remains unclear in Stage I/II, and in early-stage subgroups at risk. An international Society for Immunotherapy of Cancer (SITC) study evaluated the pre-defined consensus Immunoscore in t...
Similar Items
-
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study
by: Bernhard Mlecnik, et al.
Published: (2022-09-01) -
Multiverse of immune microenvironment in metastatic colorectal cancer
by: Marc Van den Eynde, et al.
Published: (2020-01-01) -
Metastasis immune-based scores predict patient survival
by: Bernhard Mlecnik, et al.
Published: (2020-01-01) -
Tumor spread or siege immunity: dissemination to distant metastasis or not
by: Gabriela Bindea, et al.
Published: (2021-01-01) -
Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
by: Carine El Sissy, et al.
Published: (2021-03-01)